Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis

Bone Marrow Transplant. 2022 Mar;57(3):510-512. doi: 10.1038/s41409-022-01566-0. Epub 2022 Jan 19.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Mutation
  • Neoplasm Recurrence, Local
  • Neoplasm, Residual
  • Polymerase Chain Reaction
  • Primary Myelofibrosis* / genetics
  • Primary Myelofibrosis* / therapy